Search

Search Constraints

You searched for: Author/Creator Richardson, Nicholas

Search Results

1. Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies: ACCELERATE in collaboration with the European Medicines Agency with the participation of the Food and Drug Administration. (November 2021)

2. FDA approval summary: Crizotinib for pediatric and young adult patients with relapsed or refractory systemic anaplastic large cell lymphoma. Issue 8 (13th May 2022)

4. FDA approval summary: Dalteparin for the treatment of symptomatic venous thromboembolism in pediatric patients. Issue 12 (8th September 2020)